Glycosaminoglycans are functional ligands for receptor for advanced glycation end-products in tumors

FEBS Journal

Volumn 280, Issue 10, 2013, Pages 2462-2470

  Mizumoto, Shuji ^a   Sugahara, Kazuyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

chondroitin sulfate; dermatan sulfate; GalNAc 4 sulfate 6 O sulfotransferase; heparan sulfate; Lewis lung carcinoma; proteoglycan; receptor for advanced glycation end products; tumor metastasis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHONDROITIN SULFATE; DERMATAN SULFATE; GLUCURONIC ACID; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; N ACETYLGALACTOSAMINE; PROTEOGLYCAN;

AMINO ACID COMPOSITION; CANCER CELL CULTURE; CELL SURFACE; IN VITRO STUDY; LEWIS CARCINOMA; LUNG METASTASIS; MALIGNANT TRANSFORMATION; MELANOMA CELL; METASTASIS POTENTIAL; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CHONDROITIN SULFATES; DERMATAN SULFATE; GLUCURONIC ACID; HUMANS; LIGANDS; LUNG; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; PROTEIN INTERACTION MAPPING; RECEPTORS, IMMUNOLOGIC;

EID: 84877707810     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12156     Document Type: Review

References (64)

1. Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, &, Kitagawa H, (2003) Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 13, 612-620. (Pubitemid 37244117)
2. Sugahara K, &, Mikami T, (2007) Chondroitin/dermatan sulfate in the central nervous system. Curr Opin Struct Biol 17, 536-545. (Pubitemid 350019013)
3. Bishop JR, Schuksz M, &, Esko JD, (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030-1037. (Pubitemid 46676065)
4. Fuster MM, &, Esko JD, (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5, 526-542. (Pubitemid 40942829)
5. Sasisekharan R, Shriver Z, Venkataraman G, &, Narayanasami U, (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2, 521-528. (Pubitemid 37328933)
6. Thiele H, Sakano M, Kitagawa H, Sugahara K, Rajab A, Hohne W, Leschik G, Nurnberg P, &, Mundlos S, (2004) Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. Proc Natl Acad Sci USA 101, 10155-10160. (Pubitemid 38891211)
7. van Roij MHH, Mizumoto S, Yamada S, Morgan T, Tan-Sindhunata MB, Meijers-Heijboer H, Verbeke JILM, Markie D, Sugahara K, &, Robertson SP, (2008) Spondyloepiphyseal dysplasia, Omani type: further definition of the phenotype. Am J Med Genet 146A, 2376-2384.
8. Nadanaka S, Clement A, Masayama K, Faissner A, &, Sugahara K, (1998) Characteristic hexasaccharide sequences in octasaccharides derived from shark cartilage chondroitin sulfate D with neurite outgrowth promoting activity. J Biol Chem 273, 3296-3307. (Pubitemid 28109743)
9. Clement AM, Nadanaka S, Masayama K, Mandl C, Sugahara K, &, Faissner A, (1998) The DSD-1-epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth. J Biol Chem 273, 28444-28453. (Pubitemid 28496150)
10. Uyama T, Ishida M, Izumikawa T, Trybala E, Tufaro F, Bergström T, Sugahara K, &, Kitagawa H, (2006) Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity. J Biol Chem 281, 38668-38674. (Pubitemid 46041992)
11. Miyake N, Kosho T, Mizumoto S, Furuichi T, Hatamochi A, Nagashima Y, Arai E, Takahashi K, Kawamura R, Wakui K, et al,. (2010) Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Hum Mutat 31, 966-974.
12. Dündar M, Müller T, Zhang Q, Pan J, Steinmann B, Vodopiutz J, Gruber R, Sonoda T, Krabichler B, Utermann G, et al,. (2009) Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome. Am J Hum Genet 85, 873-882.
13. Maccarana M, Kalamajski S, Kongsgaard M, Magnusson SP, Oldberg A, &, Malmström A, (2009) Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin. Mol Cell Biol 29, 5517-5528.
14. ten Dam GB, van de Westerlo EMA, Purushothaman A, Stan RV, Bulten J, Sweep FCGJ, Massuger LF, Sugahara K, &, van Kuppevelt TH, (2007) Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in VEGF binding. Am J Pathol 171, 1324-1333. (Pubitemid 47582905)
15. Sugahara KN, Hirata T, Tanaka T, Ogino S, Takeda M, Terasawa H, Shimada I, Tamura J, ten Dam GB, van Kuppevelt TH, et al,. (2008) Chondroitin sulfate E fragments enhance CD44 cleavage and CD44-dependent motility in tumor cells. Cancer Res 68, 7191-7199.
16. Vallen MJ, Massuger LF, ten Dam GB, Bulten J, &, van Kuppevelt TH, (2012) Highly sulfated chondroitin sulfates, a novel class of prognostic biomarkers in ovarian cancer tissue. Gynecol Oncol 127, 202-209.
17. Li F, ten Dam GB, Murugan S, Yamada S, Hashiguchi T, Mizumoto S, Oguri K, Okayama M, van Kuppevelt TH, &, Sugahara K, (2008) Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells. J Biol Chem 283, 34294-34304.
18. Mizumoto S, Takahashi J, &, Sugahara K, (2012) Receptor for advanced glycation end products (RAGE) functions as a receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or the sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells. J Biol Chem 287, 18985-18994.
19. Condeelis J, &, Segall JE, (2003) Intravital imaging of cell movement in tumours. Nat Rev Cancer 3, 921-930. (Pubitemid 37500177)
20. Hood JD, &, Cheresh DA, (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2, 91-100. (Pubitemid 37328796)
21. Butcher DT, Alliston T, &, Weaver VM, (2009) A tense situation: forcing tumour progression. Nat Rev Cancer 9, 108-122.
22. Kalluri R, &, Zeisberg M, (2006) Fibroblasts in cancer. Nat Rev Cancer 6, 392-401.
23. Wirtz D, Konstantopoulos K, &, Searson PC, (2011) The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer 11, 512-522.
24. Eccles SA, &, Welch DR, (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369, 1742-1757. (Pubitemid 46755391)
25. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3, 453-458. (Pubitemid 37328849)
26. Wegrowski Y, &, Maquart FX, (2006) Chondroitin sulfate proteoglycans in tumor progression. Adv Pharmacol 53, 297-321.
27. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, &, McCarthy JB, (1992) A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116, 521-531.
28. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, &, Herrlich P, (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65, 13-24. (Pubitemid 121001209)
29. Iida J, Meijne AM, Knutson JR, Furcht LT, &, McCarthy JB, (1996) Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion. Semin Cancer Biol 7, 155-162. (Pubitemid 26179262)
30. Fukatsu T, Sobue M, Nagasaka T, Ohiwa N, Fukata S, Nakashima N, &, Takeuchi J, (1988) Immunohistochemical localization of chondroitin sulphate and dermatan sulphate proteoglycans in tumour tissues. Br J Cancer 57, 74-78. (Pubitemid 18067107)
31. Iozzo RV, Sampson PM, &, Schmitt GK, (1989) Neoplastic modulation of extracellular matrix: stimulation of chondroitin sulfate proteoglycan and hyaluronic acid synthesis in co-cultures of human colon carcinoma and smooth muscle cells. J Cell Biochem 39, 355-378. (Pubitemid 19137347)
32. Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K, Marshall VR, &, Horsfall DJ, (1998) Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 4, 963-971. (Pubitemid 28183398)
33. Iozzo RV, &, Cohen I, (1994) Altered proteoglycan gene expression and the tumor stroma. EXS 70, 199-214.
34. Voutilainen K, Anttila M, Sillanpää S, Tammi R, Tammi M, Saarikoski S, &, Kosma VM, (2003) Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis. Int J Cancer 107, 359-364. (Pubitemid 37266454)
35. Iida J, Meijne AM, Oegema TR Jr, Yednock TA, Kovach NL, Furcht LT, &, McCarthy JB, (1998) A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion. J Biol Chem 273, 5955-5962. (Pubitemid 28124076)
36. Desmoulière A, Guyot C, &, Gabbiani G, (2004) The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48, 509-517. (Pubitemid 39360401)
37. Sugahara K, Okumura Y, &, Yamashina I, (1989) The Engelbreth-Holm-Swarm mouse tumor produces undersulfated heparan sulfate and oversulfated galactosaminoglycans. Biochem Biophys Res Commun 162, 189-197. (Pubitemid 19185845)
38. Ito Y, Watanabe M, Nishizawa T, Omachi T, Kobayashi T, Kasama S, Habuchi O, &, Nakayama J, (2007) The utility of formalin-fixed and paraffin-embedded tissue blocks for quantitative analysis of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase mRNA expressed by colorectal cancer cells. Acta Histochem Cytochem 40, 53-59. (Pubitemid 46743502)
39. Deepa SS, Umehara Y, Higashiyama S, Itoh N, &, Sugahara K, (2002) Specific interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner. J Biol Chem 277, 43707-43716. (Pubitemid 36157787)
40. Sugahara KN, Murai T, Nishinakamura H, Kawashima H, Saya H, &, Miyasaka M, (2003) Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 278, 32259-32265. (Pubitemid 37048419)
41. Thelin MA, Svensson KJ, Shi X, Bagher M, Axelsson J, Isinger-Ekstrand A, van Kuppevelt TH, Johansson J, Nilbert M, Zaia J, et al,. (2012) Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma. Cancer Res 72, 1943-1952.
42. Eckhardt BL, Francis PA, Parker BS, &, Anderson RL, (2012) Strategies for the discovery and development of therapies for metastatic breast cancer. Nat Rev Drug Discov 11, 479-497.
43. Yamaura T, Doki Y, Murakami K, &, Saiki I, (1999) Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice. Hum Cell 12, 197-204.
44. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, &, Karin M, (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106.
45. Ueoka C, Kaneda N, Okazaki I, Nadanaka S, Muramatsu T, &, Sugahara K, (2000) Inhibition of the midkine-mediated neural cell adhesion to culture substrates by chondroitin sulfate E. Specific molecular interactions of midkine with chondroitin sulfate E. J Biol Chem 275, 37407-37413.
46. Mizumoto S, Watanabe M, Yamada S, &, Sugahara K, (2013) Expression of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase involved in chondroitin sulfate synthesis is responsible for pulmonary metastasis. Bio Med Res Int 2013, 656319.
47. Kawashima H, Atarashi K, Hirose M, Hirose J, Yamada S, Sugahara K, &, Miyasaka M, (2002) Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAα1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J Biol Chem 277, 12921-12930. (Pubitemid 34952659)
48. Monzavi-Karbassi B, Stanley JS, Hennings L, Jousheghany F, Artaud C, Shaaf S, &, Kieber-Emmons T, (2007) Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer 120, 1179-1191.
49. Cooney CA, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ, Ferrone S, Kieber-Emmons T, et al,. (2011) Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res 13, R58.
50. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, &, Shaw A, (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267, 14998-15004.
51. Sims GP, Rowe DC, Rietdijk ST, Herbst R, &, Coyle AJ, (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28, 367-388.
52. Buckley ST, &, Ehrhardt C, (2010) The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol 2010, 917108.
53. Xu D, Young J, Song D, &, Esko JD, (2011) Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). J Biol Chem 286, 41736-41744.
54. Rao NV, Argyle B, Xu X, Reynolds PR, Walenga JM, Prechel M, Prestwich GD, MacArthur RB, Walters BB, Hoidal JR, et al,. (2010) Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. Am J Physiol Cell Physiol 299, C97-110.
55. Koch M, Chitayat S, Dattilo BM, Schiefner A, Diez J, Chazin WJ, &, Fritz G, (2010) Structural basis for ligand recognition and activation of RAGE. Structure 18, 1342-1352.
56. Park H, Adsit FG, &, Boyington JC, (2010) The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J Biol Chem 285, 40762-40770.
57. Purushothaman A, Fukuda J, Mizumoto S, ten Dam GB, van Kuppevelt TH, Kitagawa H, Mikami T, &, Sugahara K, (2007) Functions of chondroitin sulfate/dermatan sulfate chains in brain development. Critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7. J Biol Chem 282, 19442-19452. (Pubitemid 47100083)
58. Deepa SS, Kalayanamitra K, Ito Y, Kongtawelert P, Fukui S, Yamada S, Mikami T, &, Sugahara K, (2007) Novel sulfated octa- and decasaccharides from squid cartilage chondroitin sulfate E: sequencing and application for determination of the epitope structure of the monoclonal antibody MO-225. Biochemistry 46, 2453-2465. (Pubitemid 46362419)
59. Staquicini FI, Cardõ-Vila M, Kolonin MG, Trepel M, Edwards JK, Nunes DN, Sergeeva A, Efstathiou E, Sun J, Almeida NF, et al,. (2011) Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc Natl Acad Sci USA 108, 18637-18642.
60. Theocharis AD, Skandalis SS, Tzanakakis GN, &, Karamanos NK, (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277, 3904-3923.
61. Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, Pavão MS, Tzanakakis GN, &, Karamanos NK, (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279, 1177-1197.
62. Karamanos NK, &, Tzanakakis GN, (2012) Glycosaminoglycans: from 'cellular glue' to novel therapeutical agents. Curr Opin Pharmacol 12, 220-222.
63. Srikrishna G, Huttunen HJ, Johansson L, Weigle B, Yamaguchi Y, Rauvala H, &, Freeze HH, (2002) N-Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J Neurochem 80, 998-1008. (Pubitemid 34809952)
64. Zhou Z, Immel D, Xi CX, Bierhaus A, Feng X, Mei L, Nawroth P, Stern DM, &, Xiong WC, (2006) Regulation of osteoclast function and bone mass by RAGE. J Exp Med 203, 1067-1080.